DAIICHI KIGENSO KAGAKU-KOGYO (4082) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative results through Q3 reflected higher revenue and higher profit, with the growth in operating income substantially exceeding revenue growth, resulting in a highly efficient earnings expansion. Revenue was ¥26.31B (+5.0% YoY), operating income was ¥2.74B (+17.5%), ordinary income was ¥2.30B (+15.5%), and net income attributable to owners of the parent was ¥1.59B (+11.9%). The operating margin improved by approximately 1.1pt YoY to 10.4%, and profit growth exceeding revenue growth suggests relative containment of costs and SG&A expenses. Progress against the full-year plan was 85.5% for operating income, 95.9% for ordinary income, and 93.9% for net income, all exceeding the standard progress rate of 75%.

Factors Affecting Results

【Revenue】Revenue increased 5.0% YoY to ¥26.31B. Although there is no business-level breakdown because the Company operates as a single segment (manufacture and sale of chemical industrial products), progress against the full-year plan of ¥35.30B was 74.5%, which is almost in line with the standard level.

【Profit and Loss】Operating income increased 17.5% to ¥2.74B, substantially exceeding the rate of revenue growth, indicating the operation of operating leverage. Meanwhile, non-operating expenses of ¥0.81B, primarily interest expense of ¥0.35B, exceeded non-operating income of ¥0.38B, limiting ordinary income growth to 15.5% at ¥2.30B. Profit before tax of ¥2.49B included a gain on the sale of investment securities of ¥0.27B, meaning that a portion of net income of ¥1.59B (+11.9%) was boosted by a temporary factor. In conclusion, the Company achieved higher revenue and higher profit.

Segment Analysis

The Group operates as a single segment consisting of the manufacture and sale of chemical industrial products, and segment-level disclosure has been omitted.

Key Financial Indicators

【Profitability】The operating margin improved by approximately 1.1pt YoY to 10.4%, while the net margin also improved by approximately 0.4pt to 6.1%, indicating progress in expense management exceeding revenue growth. 【Cash Flow Quality】The current ratio and quick ratio were both 316.0%, securing ample short-term liquidity; however, annualized DSO was 74 days, annualized DIO was 248 days, and annualized CCC was 306 days, all of which were lengthy, indicating substantial funds tied up in inventories and accounts receivable. 【Investment Efficiency】ROE was 4.2% on a cumulative basis, corresponding to approximately 5.6% on an annualized basis, indicating relatively low capital efficiency compared with the operating margin. Total asset turnover of 0.401x was a constraining factor, while property, plant and equipment of ¥24.43B and inventories of ¥16.91B weighed on asset efficiency. 【Financial Soundness】With an equity ratio of 57.8%, a Debt/Capital ratio of 31.6%, and interest coverage of 7.79x, financial leverage was conservative and the capacity to service interest was sufficient.

Cash Flow Analysis

The cash flow statement items were not disclosed in these results, so direct assessment of operating CF, investing CF, and financing CF cannot be performed; however, fund movements can be inferred from the balance sheet. Cash and deposits were ¥8.85B, almost flat from ¥8.92B in the same period of the previous year, suggesting that cash generation and uses during the period were broadly balanced. Inventories totaled ¥16.91B, comprising raw materials of ¥6.51B, work in process of ¥2.93B, and finished products of ¥7.48B, and had increased from the same period of the previous year, suggesting that more funds may have been tied up in working capital than implied by the increase in revenue. Annualized CCC was lengthy at 306 days, indicating that delayed collection of accounts receivable of ¥7.14B, reflected in DSO of 74 days, and the extended inventory holding period, reflected in DIO of 248 days, were delaying the conversion of earnings into cash. Interest-bearing debt of ¥17.49B, centered on long-term borrowings of ¥14.59B, appears to have been used as a funding source for capital expenditures and working capital.

Quality of Earnings

Separating recurring earnings power from temporary factors, operating income of ¥2.74B appears to reflect recurring improvement in core profitability. In contrast, profit before tax of ¥2.49B included a gain on the sale of investment securities of ¥0.27B, equivalent to approximately 10.7% of profit before tax, which represents a temporary factor. Non-operating income included a foreign exchange gain of ¥0.16B, another highly volatile item. A loss on the disposal of fixed assets of ¥0.08B was also recorded as an extraordinary loss. Comprehensive income was limited to ¥0.15B, creating a substantial gap from net income attributable to owners of the parent of ¥1.59B. This was primarily attributable to a negative foreign currency translation adjustment of ¥1.32B, resulting from translation differences on overseas assets and liabilities, and does not impair the Company’s core earnings power. From an accrual perspective, the increase in working capital, namely inventories and accounts receivable, indicates that accounting profit may not have been fully reflected in cash generation.

Earnings Forecast and Guidance

Progress against the full-year company plan was 74.5% for revenue, 85.5% for operating income, 95.9% for ordinary income, and 93.9% for net income, with the profit items substantially exceeding the standard progress rate of 75% after three quarters. Accordingly, fourth-quarter operating income implied by the full-year plan was ¥0.46B, corresponding to an implicit operating margin of approximately 5.2%, substantially below the cumulative actual operating margin of 10.4%. The company plan may incorporate lower profitability or higher costs in the second half, or conservative assumptions. Whether fourth-quarter results will develop in line with the assumptions underlying the plan will be a key focus going forward.

Shareholder Returns

The Q2 dividend was ¥14.00 per share, and the full-year dividend forecast is ¥28.00, representing an increase from the previous year’s dividend of ¥12. The forecast payout ratio based on the full-year net income plan of ¥1.70B is approximately 39.9%, remaining below the 60% benchmark. Because the dividend does not include share repurchases, it is evaluated as the payout ratio and is not included in the calculation of the total return ratio. Retained earnings of ¥33.98B and cash and deposits of ¥8.85B support the Company’s capacity to pay dividends. However, because substantial funds are tied up in working capital, as indicated by CCC of 306 days, the effective cash coverage of dividends must be considered together with trends in the reduction of inventories and accounts receivable.

Risk Factors

1. Working Capital Accumulation Risk: Annualized DIO of 248 days, DSO of 74 days, and CCC of 306 days all substantially exceed generally recognized warning levels. Funds tied up in inventories of ¥16.91B and accounts receivable of ¥7.14B increase the risk of inventory write-downs and bad debts during periods of slowing demand.

2. Business Concentration Risk: Because the Company operates as a single segment focused on the manufacture and sale of chemical industrial products, diversification against market conditions for specific product groups, raw material and energy prices, and production trends in customer industries is limited.

3. Interest Rate and Foreign Exchange Sensitivity Risk: The Company carries interest-bearing debt of ¥17.49B and interest expense of ¥0.35B. Although interest coverage of 7.79x is within a sound range, an increase in refinancing rates could affect ordinary income. In addition, the foreign exchange gain of ¥0.16B is equivalent to approximately 6.0% of operating income and is a factor contributing to volatility in ordinary income.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The operating margin exceeds the industry median, while the net margin remains approximately at the same level.

Growth and Capital Efficiency

The revenue growth rate exceeds the industry median and is positioned in the upper half of the IQR.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The operating margin improved YoY and exceeded the industry median, but annualized ROE remained approximately 5.6%. Total asset turnover and working capital efficiency are the primary constraints on capital efficiency.

2. Working capital accumulation, reflected in annualized DSO of 74 days, DIO of 248 days, and CCC of 306 days, is a structural observation point indicating that the conversion of earnings into cash may be delayed even during periods of revenue and profit growth.

3. Net income included the temporary factor of a ¥0.27B gain on the sale of investment securities, representing approximately 10.7% of profit before tax. Distinguishing this from operating income and ordinary income is important when assessing recurring earnings power.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,323–¥1,399 at ±1% for the cost of equity, and ¥1,354–¥1,365 at ±0.1 for ω.

Notes:

• Because net income progress against the full-year forecast is 94%, exceeding the standard rate of 75%, forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of forecast tend to exceed their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net income is substantially compressed relative to operating income due to tax expenses, acquisition-related costs, and non-controlling interests, among other factors (net income ÷ operating income 53%). This figure reflects that compression at face value, and normalized earnings power may be higher if these factors are temporary.
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used, resulting in a timing gap relative to the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Valuation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 results were solid operationally, with profit growth materially outpacing sales growth, although working-capital intensity and non-operating financial costs remain central risks. Revenue increased 5.0% YoY to ¥26.31bn. Operating income rose 17.5% to ¥2.74bn, demonstrating favorable operating leverage. Net income attributable to owners increased 12.9% to ¥1.60bn, and EPS reached ¥65.92. Gross profit expanded 13.2% YoY to ¥7.68bn, substantially faster than revenue. The gross margin improved by 208bp YoY to 29.2%. The operating margin improved by 111bp YoY to 10.4%, placing profitability within the generally sound 8-15% range for the stated benchmark. The net margin improved by 43bp YoY to 6.1%. SG&A rose 10.9% YoY to ¥4.94bn, faster than sales, but the gross-profit increase more than absorbed this cost growth. Ordinary income increased 15.5% to ¥2.30bn, but remained below operating income because net non-operating expenses were ¥435m. Interest expense of ¥351m and derivative valuation losses of ¥247m were important drags on below-operating-line earnings. Profit before tax declined 0.5% YoY to ¥2.49bn despite operating growth, reflecting a substantially smaller extraordinary-income contribution than in the prior year. Current net income also included a ¥267m gain on sale of investment securities, partly offset by an ¥84m loss on disposal of fixed assets. Comprehensive income was only ¥150m, well below net income, owing primarily to a ¥1.32bn foreign-currency translation loss in OCI. Management's full-year sales forecast is largely consistent with the Q3 run rate, while the profit forecasts imply a sharply lower Q4 operating-profit contribution. Q3 operating income has already reached 85.5% of the full-year forecast, versus a standard 75% Q3 progress rate. The core investment debate is therefore whether the improved gross margin can be maintained while inventory, receivable collection, debt funding costs, and rare-earth supply-chain exposure are controlled.

Profitability Analysis

The annualized DuPont ROE is 5.6%, comprising a 6.1% net profit margin, 0.535x asset turnover, and 1.73x financial leverage. The profit margin is the principal positive contributor: a 208bp gross-margin expansion translated into a 111bp operating-margin expansion, while asset turnover remains modest for a manufacturer with a 37.3% PPE share of assets and a large inventory base. Financial leverage is moderate rather than excessive, with D/E at 0.73x, so the return profile is driven more by operating margin than balance-sheet leverage. The annualized 5.6% ROE remains below the 8% level generally associated with an attractive return profile, indicating that capital efficiency has not yet caught up with the earnings improvement. Revenue grew 5.0%, whereas operating income grew 17.5%, showing meaningful positive operating leverage. However, SG&A expense increased 10.9%, faster than revenue growth, so continued margin expansion requires either gross-margin resilience or tighter overhead absorption. Ordinary income was ¥435m below operating income, mainly reflecting interest expense, derivative valuation losses, and allowance-related charges within non-operating expenses. The five-factor DuPont tax burden was 0.642, equivalent to a 35.9% effective tax rate, which reduced the conversion of pre-tax earnings into net income. The interest burden was 0.909, indicating that financing costs are material but not yet severely impairing operating earnings. Interest coverage of 7.79x remains sound, but its preservation depends on stable operating income and borrowing costs. The company operates in a single chemical-products manufacturing segment, making consolidated profitability directly dependent on the performance of its core business rather than diversification across segments.

Growth Assessment

Top-line growth of 5.0% was accompanied by much stronger gross-profit and operating-profit growth of 13.2% and 17.5%, respectively, supporting the view that the current earnings expansion is margin-led rather than volume-led alone. Gross profit of ¥7.68bn rose because the gross margin improved to 29.2% from 27.1% in the prior-year period. Full-year sales guidance of ¥35.30bn implies Q3 progress of 74.5%, essentially in line with the standard 75% seasonal benchmark. Full-year operating-income guidance of ¥3.20bn implies Q3 progress of 85.5%, 10.5 percentage points ahead of the standard benchmark. Full-year ordinary-income guidance of ¥2.40bn implies 95.9% progress by Q3, and net-income guidance of ¥1.70bn implies 93.9% progress. The guidance therefore embeds a Q4 operating income of only ¥464m, compared with ¥2.74bn accumulated through Q3, suggesting management expects margin normalization, seasonality, cost increases, or conservatism. The forecast also implies Q4 sales of ¥8.99bn. The low implied Q4 ordinary income of ¥98m indicates that non-operating costs, including financing and derivative-related items, require close monitoring. Current net income was supported by a ¥267m gain on sale of investment securities; this gain represented approximately 16.7% of net income attributable to owners and is not part of core operating performance. In contrast, the operating-income improvement appears more recurring because it arose from gross-margin expansion. Inventory increased 24.3% YoY to ¥16.91bn, outpacing revenue growth and creating a material requirement for future sales conversion. Raw materials rose 39.6% YoY and work in process rose 50.4% YoY, while finished goods rose 6.7% YoY. The inventory mix consists of 38.5% raw materials, 17.3% work in process, and 44.2% finished goods; the WIP ratio is within the stated 30% benchmark, but the absolute inventory cycle remains elevated. For a rare-earth chemical producer, the sustainability of growth is sensitive to demand from advanced materials customers, pricing, raw-material availability, and foreign-exchange conditions.

Financial Health

Liquidity is strong on reported balance-sheet measures, with a current ratio and quick ratio of 316.0% and working capital of ¥24.53bn. Current assets of ¥35.89bn exceed current liabilities of ¥11.36bn by a substantial margin. Cash and deposits were ¥8.85bn, equivalent to 3.05x short-term loans of ¥2.90bn. The short-term debt ratio is 16.6%, while debt/capital is 31.6%, both consistent with a manageable capital structure. D/E of 0.73x is conservative relative to the 2.0x warning threshold. Interest-bearing debt totaled ¥17.49bn, comprising ¥2.90bn of short-term loans and ¥14.59bn of long-term loans. Current portions of long-term loans were ¥5.28bn, so total near-term debt obligations are meaningful even though current assets provide ample coverage. Cash approximately covers short-term loans plus the current portion of long-term loans, while the broader current-asset base provides an additional liquidity buffer. Interest coverage of 7.79x is sound but makes the earnings profile sensitive to further interest-rate increases or operating-profit weakness. Short-term loans increased from ¥300m to ¥2.90bn YoY, an 866.7% increase, indicating a material shift toward short-term funding. This increase should be assessed in conjunction with the rise in inventories and receivables, as it may partly fund working-capital requirements. Total equity declined 1.5% YoY to ¥37.89bn despite retained earnings increasing to ¥33.98bn, principally because accumulated OCI declined. The capital adequacy ratio decreased to 56.9% from 58.6%, but remains robust. Intangible assets fell 49.8% YoY to ¥876m and represent only 1.3% of total assets, limiting balance-sheet exposure to amortization or impairment associated with intangible assets. Treasury stock increased from ¥124m to ¥183m, a 47.6% change in carrying amount, but remains only 0.3% of total assets.

Notable B/S Changes

Short-term loans: +¥2.60bn (+866.7%) to ¥2.90bn - a material increase in short-term funding, likely linked to higher working-capital requirements; monitor refinancing exposure and cash conversion. Raw materials: +¥1.85bn (+39.6%) to ¥6.51bn - inventory accumulation materially exceeded sales growth, increasing exposure to input-price and demand risk. Work in process: +¥980m (+50.4%) to ¥2.93bn - indicates greater capital tied up in production; monitor production throughput and order conversion. Intangible assets: -¥870m (-49.8%) to ¥876m - lowers intangible-asset and amortization exposure; intangibles are only 1.3% of total assets. Property, plant and equipment: -¥2.41bn (-9.3%) to ¥24.43bn - PPE remains substantial at 37.3% of assets, reinforcing the capital-intensive manufacturing profile. Accumulated other comprehensive income: -¥1.45bn (-48.4%) to ¥1.54bn - primarily reflects adverse foreign-currency translation effects and contributed to the decline in total equity. Treasury stock: -¥59m (-47.6%) to -¥183m - increased share repurchases or other treasury-share activity reduced equity modestly.

Cash Flow Quality

Working-capital conversion is the principal earnings-quality concern. Reported receivable days are 74 days, above the 60-day warning threshold. The root cause is that trade receivables increased 14.6% YoY to ¥7.14bn, materially faster than 5.0% revenue growth. In a manufacturing context, this may reflect slower customer collections, a shift in shipment timing, or more credit-intensive sales; regardless of cause, it increases the capital required to support growth. The impact is greater reliance on liquidity and borrowing capacity, and it raises the risk that accounting earnings are not converted into cash on the same timetable. Reported inventory days are 248 days, far above the 90-day warning threshold and especially high against the 30-45 day reference range cited for steel and non-ferrous material cycles. The root cause is a ¥3.30bn YoY increase in inventories to ¥16.91bn, led by raw materials and work in process. Chemical and rare-earth manufacturing can require safety stock and long procurement lead times, but the magnitude still indicates elevated exposure to demand changes, raw-material price movements, obsolescence, and potential inventory valuation pressure. The reported annualized cash conversion cycle is 306 days, above the 120-day warning threshold. This stems from high receivable and inventory days combined with a relatively short supplier-payment cycle implied by the reported CCC. The impact is that business growth consumes substantial operating capital and can increase dependence on short-term funding, consistent with the large increase in short-term loans. Cash conversion, operating cash flow, free cash flow, and capex coverage are not assessed in this analysis.

Dividend Sustainability

The interim Q2 dividend was ¥14.00 per share. The full-year dividend forecast is ¥28.00 per share, implying a forecast dividend payout ratio of approximately 39.9% based on forecast EPS of ¥70.16. This is below the 60% sustainability benchmark and appears supportable from reported earnings. The interim dividend represented a calculated 21.4% payout ratio against Q3 cumulative net income. Retained earnings of ¥33.98bn and owners' equity of ¥37.33bn provide a substantial accounting capital buffer. Liquidity is also strong, with ¥8.85bn of cash and deposits and a 316.0% current ratio. The main constraint on dividend flexibility is not the stated payout ratio but the elevated working-capital commitment, including 248 inventory days and a 306-day cash conversion cycle. The announced ¥28.00 annual dividend appears consistent with current profitability and balance-sheet capacity, subject to maintaining cash conversion and avoiding a material deterioration in rare-earth market conditions.

Risk Assessment

Business risks include Working-capital risk: receivable days of 74, inventory days of 248, and an annualized cash conversion cycle of 306 days indicate that a large amount of capital is tied up in operations., Inventory valuation and demand risk: inventories rose 24.3% YoY to ¥16.91bn, with raw materials up 39.6% and WIP up 50.4%; weaker demand or declining raw-material prices could pressure margins and asset values., Rare-earth chemical industry risk: sourcing concentration, geopolitical restrictions, export controls, and price volatility in rare-earth inputs can affect procurement costs, production continuity, and customer demand., Foreign-exchange risk: FX gains fell to ¥164m from ¥312m YoY, while foreign-currency translation adjustments reduced OCI by ¥1.32bn, demonstrating sensitivity to currency movements., Customer collection risk: receivables rose 14.6% YoY, faster than revenue, potentially indicating longer collection cycles or increased credit exposure..

Financial risks include Funding-mix risk: short-term loans increased 866.7% YoY to ¥2.90bn, increasing refinancing sensitivity even though reported liquidity ratios remain strong., Interest-cost risk: interest expense was ¥351m and interest coverage was 7.79x; higher market rates or lower operating profit would reduce coverage., Non-operating volatility: derivative valuation losses of ¥247m and allowance-related charges of ¥154m reduced ordinary income and can introduce earnings variability., OCI and capital volatility: comprehensive income was only ¥150m despite ¥1.60bn of net income because OCI was negative ¥1.45bn, reducing reported equity resilience..

Key concerns include High inventory days are the highest-priority financial-data risk because inventory represents ¥16.91bn and can affect both cash conversion and valuation risk., The 306-day annualized cash conversion cycle is a high-impact constraint on free cash generation and may explain the increased use of short-term borrowing., Full-year profit guidance embeds a marked Q4 slowdown: Q3 progress is 85.5% for operating income, 95.9% for ordinary income, and 93.9% for net income., Current net income includes a ¥267m securities-sale gain, while ordinary income remains below operating income due to financing and other non-operating expenses., The single-segment structure concentrates exposure to conditions in chemical-products manufacturing and rare-earth-related end markets..

Investment Implications

Key takeaways include Operating performance improved meaningfully: revenue grew 5.0%, operating income grew 17.5%, and the operating margin expanded 111bp to 10.4%., The annualized ROE of 5.6% remains below the 8% benchmark, indicating that margin progress has yet to translate into strong overall capital efficiency., Balance-sheet liquidity is strong, with 316.0% current and quick ratios, while D/E of 0.73x and debt/capital of 31.6% remain manageable., Working-capital efficiency is the principal issue, with 74 DSO, 248 DIO, and a 306-day annualized cash conversion cycle., The ¥28.00 full-year dividend forecast implies an approximately 39.9% forecast payout ratio and appears aligned with earnings capacity., The large Q3 progress against full-year profit guidance makes the sustainability of gross margins and the expected Q4 earnings profile key issues..

Metrics to watch include Gross margin and operating margin, particularly whether the 29.2% and 10.4% Q3 cumulative levels can be sustained., Inventory balance, inventory days, and the mix of raw materials, WIP, and finished goods., Receivable growth and DSO relative to sales growth., Cash conversion cycle and the extent to which short-term borrowing declines as working capital normalizes., Interest expense, derivative valuation effects, and interest coverage., Foreign-exchange gains/losses and foreign-currency translation adjustments., Achievement of the FY2026 operating-income forecast of ¥3.20bn and the implied Q4 operating-income outcome of ¥464m..

Regarding relative positioning, The company presents a mixed profile: operating margins and balance-sheet liquidity are comparatively sound, while annualized ROE is modest and working-capital efficiency is weak for a manufacturer. Its low intangible-asset exposure and moderate leverage reduce M&A and solvency concerns, but the unusually long inventory and cash-conversion cycles create a more capital-intensive and potentially volatile earnings profile than the operating-margin improvement alone suggests.